• Explore /
  • Poster
  • / Clinical utility of comprehensive circulating tumor DNA (ctDNA) testing compared to standard-of-care (SoC) tissue testing in first-line (1L) metastatic colorectal cancer (mCRC) patients (pts).

Clinical utility of comprehensive circulating tumor DNA (ctDNA) testing compared to standard-of-care (SoC) tissue testing in first-line (1L) metastatic colorectal cancer (mCRC) patients (pts).

Abstract Poster

Authors

null

Manuel Benavides

Hospital Universitario Regional y Virgen de la Victoria, Málaga, Spain

Manuel Benavides , Julia Alcaide , Martina Alvarez , Esperanza Torres , Isabel Sevilla , Silvia Gil Calle , Carmen Reyna , Inmaculada Alés , Gema Durán , Roberto Wolman , Mireya Cazorla , Pedro Jimenez Gallego , Irene López , Alexandra Cantero , Ana Godoy , Richard B. Lanman , Iris Faull , Justin Odegaard , Il Jin Kim , Emilio Alba

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Anal and Colorectal Cancer

Track

Colorectal Cancer,Anal Cancer

Sub Track

Diagnostics

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 15)

Abstract #

15

Poster Bd #

A9

Abstract Disclosures

Similar Posters

First Author: Yu Aoki

Poster

2022 ASCO Gastrointestinal Cancers Symposium

Comprehensive landscape of <em>BRAF</em> variant classes, clonalities, and comutations in metastatic colorectal cancer using ctDNA profiling.

Comprehensive landscape of BRAF variant classes, clonalities, and comutations in metastatic colorectal cancer using ctDNA profiling.

First Author: Benny Johnson

First Author: John H. Strickler

First Author: Deirdre Jill Cohen